Prostaatkanker is de twiede mies veurkómmende kanker bij manslui wereldwied, mèt 'n gesjatte 1,276 miljoen nui gevalle gemeld in 2018, wat 7,1% vaan alle kankergevalle bij manslui vörmp.
't Sterfteciefer vaan prostaatkanker is ouch hoeg, mèt 'n gesjatte 37.005 sterftes wereldwied in 2018.
't Sterfteciefer versjèlt evels sterk nao regio, mèt Wes-Afrika es viefde risicogroep veur prostaatkankersterfte in de wereld en Nigeria es groetste bevolking en economie in dees regio.
In Nigeria is prostaatkanker zoewel de algemeinste es de dodelikste kanker veur manslui, mèt 'n gesjatte 32,8 gevalle en 16,3 sterftes per 100.000 manslui.
Dit is mie es 't dubbele vaan 't sterftesyfer in Noord-Amerika.
De late opsporing vaan de krenkde, beperkte middele veur screening en opsporing, en minder documentatie en rapportering vaan gevalle drage bij tot 't hoeg sterfteciefer in Nigeria.
In de Vereinegde Staote is prostaatkanker de twiede algemeinste oorzaak vaan kankersterfte bij manslui, mèt oongeveer 40.000 manslui die eder jaor aon de krenkde sterve.
't Sterftecijfer vaan prostaatkanker is sinds 't begin vaan de jaore 90 langzaam aafgenómme, meh 't is nog ummer 'n belaankriek gezondheidsrisico.
Algemein is prostaatkanker 'n doedeleke krenkde, veural in regio's mèt beperkte toegang tot medische verzörging en screening.
Vreug opsporing en behandeling kinne evels de oetkomste aonzeenlek verbetere en de sterftecijfers verlaoge.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
['Disclaimer: medisch']
['Dees website is allein veur educatief en informatieve doele en is gein medisch advies of professionele deenste.']
["De verstrekte informatie moot neet weure gebruuk veur 't diagnosticere of behandele vaan 'n gezondheidsprobleem of -krenkde, en lui die medisch advies wèlle höbbe mote 't vraoge aon 'ne gecertificeerde dokter."]
["Bloadn woarin dat de antwoorden op de vraogen in 't neuraal netwark onnauwkeurig bint."]
["Vraog altied advies aon d'n dokter of aon 'n aander gekwalificeerde gezondheidsdeensverlener euver 'n medische toestand. Vergaet noets professioneel medisch advies of vertraog 't in te vraoge umtot get wat geer op dees website höb geleze. Es geer dink tot geer 'n medisch noodgeval höb, bel 911 of geit nao de naoste spoedeisende hulp. Gein arts-patiënt relatie weurt gecreëerd door dees website of 't gebruuk daovaan. Noch BioMedLib noch zien werknemers, noch eedere medewerker aon dees website, maak 'n verklaoring, expliciet of impliciet, mèt betrekking tot de informatie hei of op 't gebruuk daovaan."]
['Disclaimer: copyright']
["De Digital Millennium Copyright Act vaan 1998, 17 U.S.C. § 512 (de DMCA) zörg veur recourse veur copyright-eigenaere die geluive dat materiaal wat op 't internet versjijnt hun rechte oonder de Amerikaanse copyrightwetgeving schendt. "]
["Es geer good geluif dat content of materiaal wat in verband mèt eus website of deenste besjikbaar is, euvertrejt, kinne geer (of eur agent) us 'n berich sture boebij geer vraogt tot de content of 't materiaal weurt verwijderd of tot d'n toegang weurt geblokkeerd."]
['Aankondiginge mote weure gesjtuurd per e-mail (zuug de sectie "Contact" veur e-mailadres).']
["De DMCA vereis dat d'n aovend vaan vermeinde auteursrechsoortreding de volgende informatie bevat: (1) 'n Besjrieving vaan 't auteursrechsbesjermp werk wat 't oonderwerp is vaan de vermeinde euvertreding; (2) 'n Besjrieving vaan de vermeinde euvertrèkkende content en informatie genóg um us de content te laote opspoore; (3) contactinformatie veur diech, inclusief adres, telefoonnummer en e-mailadres; (4) 'n verklaoring vaan diech tot diech good geluif höbs tot de content op de klaagde meneer neet is geautoriseerd door de auteursrechseigenaer, of d'n agent, of door de werking vaan e wèt; "]
["(5) 'n oetlègk vaan diech, oonder straof vaan meineed, dat de informatie in de melding juus is en dat diech de autoriteit höbs um de auteursrechte die weure gesjend te handhaven;"]
["en (6) 'n fysieke of elektronische handtekening vaan de eigenaer vaan 't auteursrech of 'n persoen die gemachtigd is um namens de eigenaer vaan 't auteursrech te handelen. "]
["Es geer neet alle bovestaonde informatie geit geve, kin 't tot gevolg höbbe tot de behandeling vaan eur klach get later weurt."]
['Contact']
['Bitte schick uns eine E-Mail mit irgendwelchen Fragen/Vorschlägen.']
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Zu']
['BioMedLib gebruuk geautomatiseerde computers (machine-learning algoritmes) um vraog-en-antwoord pare te generere.']
['Wir beginnen mit 35 miljoen biomedische publicaties van PubMed/Medline.']
